Hardy Diagnostics has just released Arcanobacterium Selective Agar (also known as Berger's Agar, Cat no. A134
), a novel medium for the isolation of Arcanobacterium haemolyticum
, especially from respiratory specimens.
Selective agents have been added to the medium to inhibit Streptococcus pyogenes
and normal oral flora without affecting the growth of Arcanobacterium haemolyticum
. Also released by Hardy Diagnostics is a bi-plate, consisting of Group A Beta Strep Selective Agar and Arcanobacterium Selective Agar (Cat. no. J134)
so that throat cultures can be effectively screened for both Group A Strep and Arcanobacterium simultaneously.
Daniel Berger a Research and Development Microbiologist at Hardy Diagnostics has prepared an article discussing the significance and potential under reporting of A.haemolyticum
, click here
to download the full text pdf from Hardy Diagnostics website.